<DOC>
	<DOCNO>NCT00343954</DOCNO>
	<brief_summary>To evaluate PK PD responses L-citrulline give orally four week patient sickle cell disease otherwise healthy .</brief_summary>
	<brief_title>PK PD Responses Oral L-Citrulline Patients With Sickle Cell Disease</brief_title>
	<detailed_description>Phase 1 , single center , open label , multiple-dose study consist screen period follow four week treatment . At least 12 male female patient , 10 year age old , sickle cell disease otherwise healthy , enrol study . PK measurement include plasma concentration L-citrulline , L-arginine , L-ornithine , L-proline follow first dose orally administer L-citrulline four week twice daily administration drug . PD measurement include intercellular vascular adhesion molecule ( ICAM , VCAM , E-selectin ) , surrogate marker sickle cell disease activity , PAT , measurement vascular function .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>1 . Male female , 10 year age old day dosing , generally healthy determine medical history , physical examination , laboratory test value 2 . Diagnosis sickle cell anemia ( Hb SS ) 3 . For female childbearing potential , negative serum pregnancy test use adequate method contraception 4 . Has sign receive copy write informed consent form approve investigator ’ Institutional Review Board ( IRB ) , understands purpose risk study agrees follow restriction schedule procedure define protocol 1 . History sicklecell–related pain crisis within two week study 2 . Pregnant breast feed 3 . Transfusion within last 90 day 4 . Creatinine &gt; 1.5 X upper limit normal 5 . SGPT &gt; 2 X upper limit normal 6 . History allergic reaction arginine citrulline product 7 . Requires chronic medication study drug discontinue study period 8 . Unable take tolerate oral medication 9 . Unreliable venous access 10 . Noncompliant regular care 11 . Participation investigational drug medical device study within previous 30 day 12 . In opinion investigator good candidate participation study</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>sickle cell disease</keyword>
</DOC>